CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells.
Bexte T, Albinger N, Al Ajami A, Wendel P, Buchinger L, Gessner A, Alzubi J, Särchen V, Vogler M, Rasheed HM, Jung BA, Wolf S, Bhayadia R, Oellerich T, Klusmann JH, Penack O, Möker N, Cathomen T, Rieger MA, Imkeller K, Ullrich E.
Bexte T, et al. Among authors: alzubi j.
Nat Commun. 2024 Sep 30;15(1):8439. doi: 10.1038/s41467-024-52388-1.
Nat Commun. 2024.
PMID: 39349459
Free PMC article.